ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-12.7%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$343M
AUM Growth
+$343M
Cap. Flow
+$46.8M
Cap. Flow %
13.66%
Top 10 Hldgs %
96.02%
Holding
15
New
–
Increased
11
Reduced
–
Closed
1

Top Buys

1
ARWR icon
Arrowhead Research
ARWR
$16M
2
MRUS icon
Merus
MRUS
$9.65M
3
ARVN icon
Arvinas
ARVN
$8.87M
4
BPMC
Blueprint Medicines
BPMC
$8.69M
5
QURE icon
uniQure
QURE
$4.07M

Top Sells

1
DNTH icon
Dianthus Therapeutics
DNTH
$14M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$49.9M 7.34%
781,539
+136,000
+21% +$8.69M
ARWR icon
2
Arrowhead Research
ARWR
$3.05B
$48.2M 7.08%
1,047,440
+347,014
+50% +$16M
ARVN icon
3
Arvinas
ARVN
$568M
$46.8M 6.88%
695,247
+131,796
+23% +$8.87M
SPRO icon
4
Spero Therapeutics
SPRO
$116M
$45.9M 6.75%
5,281,504
+317,323
+6% +$2.76M
RGNX icon
5
Regenxbio
RGNX
$451M
$37.1M 5.46%
1,118,684
+105,088
+10% +$3.49M
MRUS icon
6
Merus
MRUS
$4.98B
$33.4M 4.9%
1,261,534
+365,032
+41% +$9.65M
FDMT icon
7
4D Molecular Therapeutics
FDMT
$288M
$26.5M 3.9%
1,755,506
+245,562
+16% +$3.71M
QURE icon
8
uniQure
QURE
$896M
$16.3M 2.39%
901,490
+225,284
+33% +$4.07M
AMYT
9
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$13.6M 1.99%
1,640,000
– –
PVLA
10
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$11.2M 1.65%
3,708,882
+512,355
+16% +$1.55M
ARGX icon
11
argenx
ARGX
$43.6B
$7.57M 1.11%
24,000
+1,800
+8% +$568K
GMAB icon
12
Genmab
GMAB
$15.3B
$6.06M 0.89%
167,500
+40,000
+31% +$1.45M
DNTH icon
13
Dianthus Therapeutics
DNTH
$759M
– –
-3,155,082
Closed -$14M
SPY icon
14
SPDR S&P 500 ETF Trust
SPY
$658B
– –
0
– –
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –